SERENA-3

• Research type

  Research Study

• Full title

  A Randomised, Open-Label, Parallel-Group, Pre surgical Study to Investigate the Biological Effects of AZD9833 in Women with ER-positive, HER2-negative Primary Breast Cancer (SERENA-3)

• IRAS ID

  1003380

• Contact name

  John Forsyth Russell Robertson

• Contact email

  John.Robertson@nottingham.ac.uk

• Sponsor organisation

  AstraZeneca AB

• Eudract number

  2020-001079-33

• Research summary

  Summary of Results

  Summary of the study results is published at the following web site: https://gbr01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fclick.pstmrk.it%2F3t%2Fwww.trialsummaries.com%252F%2FNBTI%2Fl_e1AQ%2FAQ%2F7c1bdfe2-0052-4640-bf37-98218d6ecde4%2F1%2F8HYW5Lx9tp&data=05%7C02%7Cgmcentral.rec%40hra.nhs.uk%7C42345b9d860743dd7dd408dc894a387c%7C8e1f0acad87d4f20939e36243d574267%7C0%7C0%7C638536199070814744%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=jvak8e6n0cm%2BdAnLRm696G3o%2FkmZO8mZLG1JJgCGMrQ%3D&reserved=0

• REC name

  North West - Greater Manchester Central Research Ethics Committee

• REC reference

  20/NW/0381

• Date of REC Opinion

  16 Nov 2020

• REC opinion

  Further Information Favourable Opinion